Agenus, Inc. (AGEN)
7.67
-0.42
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.67
0.00 (0.00%)
After-Hours: 19:58
Agenus Market Cap : 326.86M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 344.76M |
| August 20, 2026 | 319.19M |
| August 19, 2026 | 352.00M |
| August 18, 2026 | 320.90M |
| August 17, 2026 | 304.70M |
| August 14, 2026 | 311.95M |
| August 13, 2026 | 298.31M |
| August 12, 2026 | 294.05M |
| August 11, 2026 | 291.06M |
| August 10, 2026 | 298.31M |
| August 07, 2026 | 296.60M |
| August 06, 2026 | 319.19M |
| August 05, 2026 | 331.55M |
| August 04, 2026 | 319.73M |
| August 03, 2026 | 301.24M |
| July 31, 2026 | 288.91M |
| July 30, 2026 | 304.71M |
| July 29, 2026 | 255.40M |
| July 28, 2026 | 254.24M |
| July 27, 2026 | 236.14M |
| July 24, 2026 | 230.36M |
| July 23, 2026 | 238.45M |
| July 22, 2026 | 213.03M |
| July 21, 2026 | 214.95M |
| July 20, 2026 | 191.45M |
| Date | Value |
|---|---|
| July 17, 2026 | 192.99M |
| July 16, 2026 | 192.61M |
| July 15, 2026 | 192.99M |
| July 14, 2026 | 195.69M |
| July 13, 2026 | 235.75M |
| July 10, 2026 | 129.05M |
| July 09, 2026 | 124.81M |
| July 08, 2026 | 125.20M |
| July 07, 2026 | 134.83M |
| July 06, 2026 | 131.36M |
| July 02, 2026 | 134.44M |
| July 01, 2026 | 131.36M |
| June 30, 2026 | 117.88M |
| June 29, 2026 | 121.34M |
| June 26, 2026 | 116.72M |
| June 25, 2026 | 110.94M |
| June 24, 2026 | 112.48M |
| June 23, 2026 | 118.26M |
| June 22, 2026 | 117.11M |
| June 18, 2026 | 115.57M |
| June 17, 2026 | 114.02M |
| June 16, 2026 | 114.80M |
| June 15, 2026 | 125.20M |
| June 12, 2026 | 127.12M |
| June 11, 2026 | 130.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Iovance Biotherapeutics, Inc. | 3.655B |
| Novavax, Inc. | 1.459B |
| Fate Therapeutics, Inc. | 284.15M |
| Amgen, Inc. | 239.94B |
| Anika Therapeutics, Inc. | 285.19M |
Market Cap Related Metrics
| PE Ratio | 2.893 |
| PS Ratio | 2.136 |
| Price | 7.67 |
| Earnings Yield | 34.56% |
| Operating PE Ratio | 7.898 |
| Normalized PE Ratio | 7.684 |